Abstract
Docosahexaenoic acid (DHA, 22:6Δ4,7,10,13,16,19) is the longest chain and most unsaturated fatty acid commonly found in biological systems [1]. It represents the extreme example of the important class of fatty acids known as omega-3s. Primarily through dietary studies, this fatty acid has been linked to an enormous variety of human afflictions including cancer [2, 3], heart disease [4], rheumatoid arthritis [5], lupus [6], alcoholism [7], blindness [8], respiratory diseases [9], peroxisomal disorders [10], cystic fibrosis [11], schizophrenia [12], depression [13], malaria [14], multiple sclerosis [15] and even migrane headaches. In order for one simple molecule to affect so many seemingly unrelated processes it must function at a fundamental level, common to most cells. It has been suggested that this level is in controlling membrane structure and function [16]. Due to its extreme chain length and unsaturation it should be easier to demonstrate a unique role for DHA in membrane structure/function than it will be for other shorter, less unsaturated fatty acids commonly found in membranes. Reviewed here is the possible involvement of DHA in membrane lipid domains.
Current Organic Chemistry
Title: Docosahexaenoic Acid and Membrane Lipid Domains
Volume: 4 Issue: 11
Author(s): William Stillwell
Affiliation:
Abstract: Docosahexaenoic acid (DHA, 22:6Δ4,7,10,13,16,19) is the longest chain and most unsaturated fatty acid commonly found in biological systems [1]. It represents the extreme example of the important class of fatty acids known as omega-3s. Primarily through dietary studies, this fatty acid has been linked to an enormous variety of human afflictions including cancer [2, 3], heart disease [4], rheumatoid arthritis [5], lupus [6], alcoholism [7], blindness [8], respiratory diseases [9], peroxisomal disorders [10], cystic fibrosis [11], schizophrenia [12], depression [13], malaria [14], multiple sclerosis [15] and even migrane headaches. In order for one simple molecule to affect so many seemingly unrelated processes it must function at a fundamental level, common to most cells. It has been suggested that this level is in controlling membrane structure and function [16]. Due to its extreme chain length and unsaturation it should be easier to demonstrate a unique role for DHA in membrane structure/function than it will be for other shorter, less unsaturated fatty acids commonly found in membranes. Reviewed here is the possible involvement of DHA in membrane lipid domains.
Export Options
About this article
Cite this article as:
Stillwell William, Docosahexaenoic Acid and Membrane Lipid Domains, Current Organic Chemistry 2000; 4 (11) . https://dx.doi.org/10.2174/1385272003375860
DOI https://dx.doi.org/10.2174/1385272003375860 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Complications of Diabetes: An Insight into Genetic Polymorphism and Role of Insulin
Recent Patents on Inflammation & Allergy Drug Discovery Effects of the Natural Isoflavonoid Genistein on Growth, Signaling Pathways and Gene Expression of Matrix Macromolecules by Breast Cancer Cells
Mini-Reviews in Medicinal Chemistry Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review
Current Cardiology Reviews An Update on the Role of the Quality of LDL in Cardiovascular Risk:The Contribution of the Universities of Palermo and Zurich
Recent Patents on Cardiovascular Drug Discovery Sirolimus: A Novel Immunosuppressive Drug in Heart Transplantation
Recent Patents on Cardiovascular Drug Discovery Effects of CYP2C19 Polymorphism on Endothelial Function, Arterial Stiffness and Inflammation in Coronary Artery Disease Patients Under Clopidogrel Treatment
Current Pharmaceutical Design Peripheral Biomarkers to Assess Suicide Risk
Current Psychiatry Reviews Predementia and Dementia Syndromes: Possible Role of Lipoprotein Metabolism
Vascular Disease Prevention (Discontinued) Free Radical Scanvenging and Antioxidant Effects of Some Anthraquinone Derivatives
Medicinal Chemistry Chemistry of Plant Dyes: Applications and Environmental Implications of Dyeing Processes
Current Environmental Engineering Lung Cancer Brachytherapy: Robotics-Assisted Minimally Invasive Approach
Current Respiratory Medicine Reviews New Challenges for ACE-Inhibitors in Vascular Diseases
Drug Design Reviews - Online (Discontinued) Children with Chronic Kidney Disease and Hypertension: Could Hypertension Footprints be Early Biomarkers?
Current Hypertension Reviews Vascular Inflammation in Cardiovascular Disease: Is Immune System Protective or Bystander?
Current Pharmaceutical Design Effects of Tai Chi Exercise on Physical and Psychological Health of Older People
Current Aging Science Genetic Polymorphism and Tumor Immunotherapy
Current Pharmacogenomics Squalene as Novel Food Factor
Current Pharmaceutical Biotechnology Structural Chromosome Abnormalities Associated with Obesity: Report of Four New Subjects and Review of Literature
Current Genomics Serum Amyloid A and Its Potential Physiological / Pathological Functions - an Overview of Patents
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Anesthesia and Postoperative Cognitive Dysfunction (POCD)
Central Nervous System Agents in Medicinal Chemistry